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RESEARCH ARTICLE
Childhood ADHD and treatment outcome: 
the role of maternal functioning
Pernille Darling Rasmussen1,2,3,7* , Ole Jakob Storebø1,2,4, Yael Shmueli‑Goetz6, Anders Bo Bojesen3, 
Erik Simonsen2,5 and Niels Bilenberg3
Abstract 
Background: Relatively little is known about the role of maternal functioning in terms of attention deficit hyperac‑
tivity disorder (ADHD) symptoms, attachment style and resilience as predictive factors for treatment outcome when 
offspring are diagnosed with ADHD.
Objective: To investigate whether maternal functioning is associated with treatment outcome in children with 
ADHD.
Methods: The study formed part of a larger naturalistic observational study of children with ADHD. A battery of self‑
report measures was used to assess selected factors in maternal functioning at the point of referral (baseline data); 
adult ADHD‑symptoms, adult attachment style and adult resilience. Associations between these domains and child 
treatment response were subsequently examined in a 1‑year follow up.
Results: Maternal ADHD‑symptoms and degree of resilience were significantly correlated to symptom reduction in 
offspring diagnosed with ADHD. However, the association between maternal attachment style and child treatment 
response as measured by the ADHD‑RS did not reach statistical significance.
Conclusion: To our knowledge, this is the first study to consider potential protective factors along with risk factors 
in maternal functioning and the impact on child treatment outcome. The study contributes to our knowledge of the 
potential role of maternal functioning in treatment outcome for children with ADHD.
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Background
Attention deficit hyperactivity disorder (ADHD) is the 
most commonly occurring neurodevelopmental disor-
der in childhood with a prevalence ranging from 3 to 5% 
and symptoms often continuing into adulthood [1]. It is 
characterized by a number of core symptoms including 
inattention, hyperactivity and impulsivity [2]. Both the 
DSM-5 and ICD-10 criteria require excessive inatten-
tion, hyperactivity, and impulsivity to be inconsistent 
with the developmental level and to be pervasive [3, 4]. 
According to the DSM-5 three presentations of ADHD, 
differentiated on the basis of symptom load, are com-
monly referred to: combined-type, inattentive-type and 
hyperactive/impulsive-type. For a formal diagnosis, the 
symptoms have to be present for at least 6  months and 
result in impairment in more than one setting before the 
age of 6 (ICD-10) or 12 (DSM-5) (WHO 1992, [4]).
Maternal ADHD, attachment style, and resilience
The etiology of ADHD is multifactorial, as both genetic 
and environmental factors have been evidenced in the 
development of ADHD [5, 6]. For example, a relative 
with ADHD [7], an increase in Copy Number Variation 
(CNV, [8]), prematurity [9] and some form of neglect 
(Thapar et al. 2012) have all been implicated. Moreover, 
numerous studies have found ADHD to be associated 
with a poor prognosis (e.g. more divorces, higher rates 
of substance abuse disorders in adulthood, and increased 
mortality rate) [11–13]. Furthermore, the prognosis of 
ADHD worsens in the presence of comorbidity [11, 14]. 
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Parent and child ADHD are found to be significantly 
associated, as well as parent and child conduct problems 
[15]. However, factors associated with the developmental 
progression and the long-term prognosis of ADHD are 
not fully understood [15–17] and hence, a greater focus 
on the developmental progression of ADHD is required. 
Whereas studies converge in proposing that parental 
psychopathology poses a high risk of transmission to off-
spring, relatively little is known about the role of mater-
nal functioning in terms of attention deficit hyperactivity 
disorder (ADHD) symptoms, attachment style and resil-
ience as predictive factors for treatment outcome when 
offspring are diagnosed with ADHD.
Maternal ADHD may be a potential risk factor in the 
development of offspring ADHD [18–21]. Moreover, in 
a recent study on associations between parental psychi-
atric disorders and offspring ADHD, maternal diagno-
sis showed stronger associations with child ADHD than 
paternal diagnosis [22]. Despite research establishing a 
link specifically between parental ADHD and parent-
ing, measured as the level of home chaos, and parenting 
practices assessed through self-reports [23], to date there 
have been no studies investigating the role of maternal 
ADHD symptomatology as a prognostic factor in off-
spring treatment outcome.
In addition to the contribution of maternal ADHD 
symptoms to the increased risk of offspring develop-
ing ADHD, the quality of the mother–child relation-
ship has also come under scrutiny. Indeed, both ADHD 
and attachment have been proposed as risk factors [24]. 
Reviewing the literature on ADHD and attachment, we 
found a clear association between ADHD and inse-
cure attachment. When one condition was present, this 
increased the risk of developing the other. This under-
lines that ADHD and insecure attachment may consti-
tute mutual risk factors [25]. In a recent comprehensive 
review of parental self-reported attachment style and car-
egiving, adult attachment security was consistently asso-
ciated with more positive parenting whereas insecurity 
was related to more negative parenting [26]. These find-
ings underscore the importance of investigating mater-
nal ADHD-symptoms and attachment style as part of a 
broad assessment of maternal functioning. Alongside the 
contribution of adult attachment to maternal function-
ing, a growing body of research suggests that resilience 
is also a key factor, with greater resilience associated with 
psychological adaptation and functioning in the face of 
adversity [27–29]. Broadly, resilience theory focuses on 
understanding healthy development in the face of risk, 
and on strengths as opposed to weaknesses. It has been 
defined as a “pattern of positive adaptation in the con-
text of past or present adversity” [30]. Critically, resil-
ience does not suggest the absence of adversity or risk, 
but rather highlights the presence of protective processes 
leading to healthy adaptation. Whilst definitions and 
measurement of resilience vary considerably from study 
to study and the scientific value of the concept generally 
has been debated and challenged [31] resilience has been 
found to influence treatment response across different 
manifestations of adversity. These include chronic illness, 
psychiatric disorders and school bullying [32, 33].
In this study, the focus is on the significance of mater-
nal resilience for parenting in situations where the child 
needs extra support.
The current study
The aim of the present study was to examine associations 
between mothers’ functioning and treatment response in 
their children diagnosed with ADHD who are receiving 
care as usual.
We hypothesized that maternal self-reported ADHD 
symptoms; self-reported attachment style and mater-
nal resilience would all be significantly correlated with 
treatment outcome. More specifically, we anticipated the 
following; (1) higher maternal ADHD-symptom scores 
would be associated with lower ADHD symptom reduc-
tion in offspring within the first year of treatment. (2) 
Higher scores for self-reported anxiety or ambivalence 
on the attachment style questionnaire are associated 
with lesser symptom reduction in offspring. (3) A higher 
degree of self-reported maternal resilience is associated 
with better treatment response in offspring diagnosed 
with ADHD.
Methods
The current study was part of a naturalistic observational 
study exploring different aspects of maternal function-
ing expected to influence treatment response in children 
diagnosed with ADHD.
Participants
The families participating were recruited from two child 
psychiatric outpatient clinics in Region Zealand, Den-
mark. The four interviewers participating were the same 
at the two sites; two conducting maternal attachment 
interviews and two conducting child attachment inter-
views. Sixty-seven (N = 67) child-mother dyads were 
included in the follow up.
Of the 67 mothers, 64 (95.5%) provided adequate 
responses on the baseline questionnaires to include for 
analysis. Three dyads were excluded from the analysis as 
they had not responded to all the questions. Age, gender 
distribution and the diagnoses of the children, along with 
other sample characteristics of parents and children can 
be seen in Table 1a and b. The mean age was 9.1 years, 
with children ranging in age from 7 to 12 years. A large 
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proportion of the children came from one-parent house-
holds (53%) with the rest living together with both bio-
logical parents. Fifty-four (84.4%) responders reported a 
history of psychiatric illness in parents, siblings or grand-
parents. The children received Care as usual according 
to national guidelines [34]. At 3 months follow up, 43.8% 
of the children received medical treatment increasing to 
70.3% at 6 months follow up, and 71.9% at 9 and 73.4% 
12 months follow up. There were no reports of children 
dropping out of treatment during the 1-year follow up.
Measures
Maternal measures
Resilience in Adults Scale (RSA; [35, 36])
Maternal resilience was measured by the Resilience in 
Adults Scale (RSA)—a 33-item self-report scale for meas-
uring resilience in adults. The scale covers six dimensions 
assessing protective factors at the personal level as well as 
at a family and a social level. The RSA is based on a seven 
point semantic differential scale with a positive attribute 
at the high end of the scale and a negative attribute at the 
low end of the scale. An example of a positive attribute 
in Personal Competence is ‘‘I know if I continue, I will 
succeed’’. Half of the items are reversed to reduce acqui-
escence biases. The maximum score achievable is 231 
(high resiliency) and the lowest possible score is 33. The 
scale has been found reliable for distinguishing clinical 
samples versus the normal population [37–39].
The Adult ADHD Self‑Report Scale (ASRS 1.1; [40])
Maternal ADHD symptoms were measured using the 
Adult ADHD Self-Report Scale (ASRS 1.1, short version 
of 6 items, two dimensions). The ASRS 1.1 is a 6-item 
screening version of a longer 18-item scale. It is used to 
assess ADHD symptoms in the previous 6  months and 
includes four items on inattention and two on hyperac-
tivity. Symptoms are rated on a 5-point response scale 
(never—scored 0, rarely—1, sometimes—2, often—3, 
and very often—4). The total score ranges from 0 to 24. 
In a convenience subsample of subscribers to a large 
health plan in the US, the ASRS Screener was admin-
istered twice to assess test–retest reliability and then a 
third time together with a clinical interviewer. The ASRS 
Screener was found to be in high concordance with clini-
cian diagnoses. Internal consistency reliability was in the 
0.63–0.72 range and test–retest reliability (Pearson cor-
relations) in the 0.58–0.77 range [41].
Experiences in Close Relationships Scale—Revised (ECR‑R; 
[42])
Maternal attachment style was measured using the Expe-
riences in Close Relationships Scale—Revised (ECR-R)—
36 items in total, 18 items assessing romantic attachment 
anxiety (model of self ) and 18 items assessing roman-
tic attachment avoidance (model of others). The ques-
tionnaire is a widely used self-report measure of adult 
romantic attachment and is based on the theoretical 
assumption that anxiety and avoidance are the two fun-
damental dimensions underlying attachment. Items are 
rated on a 7-point Likert scale ranging from 0 (strongly 
disagree) to 6 (strongly agree). In a study by Sibley and 
colleagues psychometric properties (i.e., the test–retest 
reliability, convergent, and discriminant validity) of the 
ECR-R were investigated and documented [43]. For the 
current study, participating parents were instructed to 
include previous and current relationship experiences 
when answering the questions.
Child measures
K‑SADS‑PL; [44, 45]
The children were screened using the Schedule for Affec-
tive Disorders and Schizophrenia for School-aged Chil-
dren, Present and Lifetime Version (K-Sad-PL).
The interview is a valid and widely established diag-
nostic measure and it allows clinicians to classify chil-
dren and adolescents with respect to their psychiatric 
Table 1 (a) Child characteristics, (b) family characteristics
n %
a
 Gender
  Male 46 71.88
  Female 18 28.13
   Age at baseline—mean (SD) = 9.1 (1.3)
 ADHD subtype
  Combined type 50 78.1
  Inattentive type 14 21.9
 Comorbidity
  None 51 79.7
  Oppositional defiance disorder 5 7.8
  Autism spectrum 4 6.3
  Other 4 6.3
b
 Parent job status
  Unemployed 15 23.4
  Employed or student 42 65.6
  No information 7 10.9
 Household type
  Nuclear family 30 46.9
  Split family 34 53.1
 Psychiatric history
  No 9 14.1
  Yes 54 84.4
  No information 1 1.6
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diagnoses according to DSM-IV systems. In a recent 
study, the convergent and divergent validity of two diag-
nostic groups, anxiety disorders and ADHD was inves-
tigated. It was concluded that the K-SADS-PL generates 
valid diagnoses of anxiety and ADHD including the pre-
dominately inattentive subtype [46].
ADHD‑rating scale (ADHD‑RS; [47])
Child ADHD symptoms were measured using the 
revised ADHD-RS [48, 49] (translated into Danish and 
validated) to assess the severity of ADHD symptoms in 
children aged 4–17  years. It consists of 26 items load-
ing on to attention deficit, hyperactivity/impulsivity and 
behavioral problems. Each item is rated from 0, denot-
ing never/rarely, to 3, denoting very often. The total score 
ranges from 0 to 78. The schedule can be administered 
by teachers and parents and has been found to be valid 
and reliable when measuring symptom load in a clinical 
population [47, 50].
Procedure
Initial identification was based on referral diagnosis 
based on ICD-10 (ADHD: combined-type, inattentive-
type and hyperactive/impulsive-type) followed by a clini-
cal evaluation in order to establish whether the family 
met the inclusion criteria.
In order to lower the risk of selection bias, we applied 
consecutive recruitment, as all the families with chil-
dren in the appropriate age range presenting the relevant 
referral diagnosis, were invited to participate.
The data obtained through questionnaires and inter-
views in the two-stage inclusion process and a 1-year fol-
low up period were analysed using structural equation 
modeling and mixed effects modeling for repeated meas-
ures (Fig. 1).
During the recruitment phase, 203 children were 
referred with a possible diagnosis of ADHD. Only chil-
dren in the age range of 7–12 representing middle child-
hood were subsequently invited to participate in the 
study. Exclusion criteria further included children who 
were adopted or living in foster care and children with 
major handicaps, such as hearing impairment or learn-
ing disabilities, preventing them from participating in 
and completing the interviews. Children who during the 
inclusion procedure were suspected of psychosis or who 
had an IQ below 70 were excluded.
Those who met the above criteria were invited to par-
ticipate and were given further information about the 
study in a telephone call by the 1st author. The second 
stage of inclusion involved a formal assessment of ADHD 
diagnosis, using the Schedule for Affective Disorders and 
Schizophrenia for School-aged Children, Present and 
Lifetime Version (K-Sad-PL) [44, 45].
Only patients assigned an ADHD/ADD diagno-
sis according to DSM-V with ADHD (314.01) or ADD 
(314.00) in step two were included for follow up. The 
included families attended both a clinical and a research 
track separated from each other (Fig. 2).
Apart from exchanging information on treatment initi-
ation, child IQ and in the event of drop out from medical 
treatment, the research project was separated from the 
clinical track.
Care as usual
The children included all received care as usual consist-
ing of standard medical treatment with methylphenidate 
as first choice for moderate and severe ADHD. The inter-
ventions were standardized and formalized according to 
national guidelines [34].
In Denmark, clinical guidelines adhere to recommen-
dations from NICE-guidelines [51]. Recommendations 
are divided into three age groups; pre-school children, 
school-age children and young people with ADHD and 
moderate impairment and school-age children and 
young people with severe ADHD and severe impair-
ment. For the school-aged children/moderate impair-
ment, group-based parent-training/education programs 
are recommended as first-line treatment. Drug therapy 
is recommended only for those with “severe symptoms 
and impairment or for those with moderate levels of 
impairment who have refused non-drug interventions, 
or whose symptoms have not responded sufficiently to 
parent-training/education programs”. When the child has 
severe ADHD/impairment, medical treatment is recom-
mended as the first line. All the participating children in 
this study were school-aged children. The research pro-
ject was not involved in choosing treatment, but was 
informed from the clinical track that no families received 
additional treatment initiatives than that described in the 
standard program. The compliance rate was excellent, as 
there was no reports of dropout from treatment during 
the 12 months of follow up.
Baseline screening of parents
Mothers were asked to complete questionnaires regard-
ing themselves. The questionnaires screened for ADHD 
symptoms using the ASRS 1.1, assessed attachment styles 
as relating to current romantic relationships using the 
ECR, and measured the degree of resilience using the 
RSA. All questionnaires were sent as links by e-mail from 
the online data managing system Easytrial.
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Easytrial ©
In order to obtain a high response rate in the follow-up 
period, we used the Easytrial© online clinical data man-
agement system. All questionnaires from the baseline 
procedure as well as the follow up sequence were sent 
out as links to the parents by e-mail. The system provided 
an opportunity to monitor non-responders and send out 
‘gentle reminders’. Responses were collected directly in a 
secured database compliant with good clinical practice 
(GCP) and database security legislation.
Follow up
The families progressed to the follow up 3 months after 
the initial assessment (Fig. 3).
This delay was to ensure that the assigned treatment 
had been initiated. The attachment assessment was con-
ducted at the child psychiatric clinics by four trained 
interviewers. The interviewers were not involved in treat-
ment and had no prior knowledge of the families. The 
two interviewers of the mothers were blinded to results 
of the child assessment and vice versa.
The follow up consisted of four ADHD-symptom 
screenings completed every third month within the first 
year of inclusion. The ADHD-RS was sent to the parents 
Stage one: Clinical assesment
(n=203)
Stage two: 
ADHD confirmed
Agreed to parcipate
IQ>70:
Invited to parcipate in K-SADS
(n=101)
Excluded due to:
Drop out (n=5)
ADHD not confirmed on 
K-SADS (n=29)
ADHD confirmed on K-SADS:
Included in project
(n=67)
Excluded due to:
ADHD not confirmed 
IQ <70
Declined to parcipate
(n=102)
Fig. 1 Two‑stage inclusion process
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Inclusion process in two consecuve stages:
(1. Clinical assesment 2. K-SADS)
Included families connued in two separated tracks:
1. Research track:
Baseline-data collected 
Follow up, consisng of 4 
assesment points with 
ADHD-RS, initated three 
months aer start of 
treatment in the clinical 
track.
Mother and child 
aachment assesment 6 
months into follow up.
Informaon exchange 
between research and 
clinical track:
1. Date of treatment start
2. Child IQ
3. Reg. any drop out
4. Informaon of 
relevance to the clinicians
2. Clinical track:
Standard treatment with 
psycho-educaon, non-
manualized parenng 
training and medical 
treatment for moderate 
and severe ADHD with 
methylphenidate as drug 
of choice.
Fig. 2 Overview of clinical and research track
Fig. 3 Details of research track during follow up
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for assessment of ADHD-symptom load in their children. 
The observed change (slope) in ADHD-RS from base-
line to the 12  month follow up represents the primary 
outcome’.
In one-parent households, the schedule was sent to the 
household in which the child was residing. More than 
half (53%) of the families were one-parent households 
and only in one family was the child residing with the 
father.
Data analysis
Treatment response was measured as the change in the 
ADHD-RS scale over the course of the 12  months of 
follow up. The change was calculated as the best fitting 
linear slope for each patient with time as a predictor of 
ADHD-RS. Due to some missed self-reports, this slope 
was in some cases based on only two observations in the 
follow up sequence with the other three missing (baseline 
and four follow up ADHD-RS measurements). A random 
effects linear regression was used to predict the slope of 
ADHD-RS change for each child. This slope is used as a 
continuous measure of treatment response. For instances 
of missing baseline measurements, the baseline score was 
approximated by an intercept estimate based on other 
measurements available. Data on missed self-reports 
is provided in Table  2. Random intercepts and slopes 
were predicted using a random effects linear regression 
model, with repeated measures (baseline and four fol-
low up ADHD-RS measurements) nested in patients. In 
a set of linear regression models, each patient’s predicted 
slope (change in ADHD-RS) was regressed on ECR, RSA 
and ASRS with and without adjustment for gender, age, 
family type, medical treatment status, familial psychiatric 
history and the number of missing data points out the five 
follow up measurements. This last element is included to 
estimate and control for any possibly association between 
non-attendance and treatment effect. Control variables 
and background variables are summarized using fre-
quency tables, means and standard deviations.
The ECR, RSA and ASRS scores used are latent varia-
ble predictions derived from structural equation models. 
ECR and RSA items are modeled assuming multivari-
ate normality. ASRS items are considered ordinal items 
and modeled using a logit link function. All three latent 
variable predictions are standardized with means at 0 and 
variances fixed to 1. The latent variable approach has the 
advantage of removing the residual (unexplained by the 
latent factor) variance for each item when predicting the 
latent variable. Measurement error associated with psy-
chometric scales is minimized in this way.
Because of some missing data on covariates, we used 
a full information maximum likelihood estimator imple-
mented in Stata 14. Means and variances as well as covar-
iance for exogenous variables were estimated and used as 
the basis for corrected regression estimates. Missing data 
due to non-attendance at the follow up measurements 
were assumed to be random, i.e. not associated with the 
unobserved outcome measurement. This assumption was 
substantiated by a missing data analysis showing no sig-
nificant association between baseline ADHD-RS score 
and missing data (RR = 1.02, p = 0.47) and between the 
ADHD-RS score preceding  (t−1) a missing data incident 
(RR = 1.01, p = 0.66). Mixed effects Poisson models were 
used for the missing data analysis.
Results
In the follow up sequence, 92.2% (N = 59) had a maxi-
mum of one missed self-report.
Whilst all fathers were invited to participate and all 
consented to do so, only a minority actually completed 
the questionnaires (22.4%). Consequently, the paternal 
response rate was too low to include for further analysis. 
Complete information from all planned assessments was 
obtained for 62.5% (N = 40) of the children. Two children 
were only measured twice from baseline to the 12 month 
follow up. Table 2 presents the descriptive results, includ-
ing means, standard deviations and number of observa-
tions for ECR, RSA and ASRS as well as ADHD-RS at 
baseline, follow up and the overall ADHD-RS reduction 
as predicted in a random effects regression. Correlations 
are provided in Additional file 1: Table S1. ADHD-RS was 
on average reduced by 12.15 points as predicted in the 
random effects regression. The mean ADHD-RS at base-
line was 43.1 and reduced to 30.25 one year after initiat-
ing treatment.
Table 2 Follow up data
The ADHD-RS reduction is a linear prediction from a mixed effects model. This 
a reflection of the observed average reduction from baseline to the 12 months 
follow up but allowing for missing data points caused by non-attendance
ADHD-RS ADHD-Rating Scale, ASRS 1.1 Adult ADHD Self-Report Scale, RSA 
Resilience Scale for Adults, ECR Experiences in Close Relationships
Mean SD n
Child measurements
 ADHD‑RS reduction − 12.15 6.46 64
 ADHD‑RS baseline 43.11 12.53 53
 ADHD‑RS 3 months 37.36 12.24 61
 ADHD‑RS 6 months 34.56 13.33 59
 ADHD‑RS 9 months 31.31 13.45 59
 ADHD‑RS 12 months 30.25 14.44 57
Parent measurements
 ASRS 1.1 28.05 14.57 59
 RSA 146.07 31.12 57
 ECR 166.75 40.11 56
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Predicting ADHD‑RS reductions
The following demographic variables were included in 
the analysis: gender, age, family history of mental ill-
ness and whether the child is living in a one or two par-
ent household. A binary indicator of medical treatment 
and the number of non-attendances were also included 
as covariates. Table  3 show regression estimates for the 
association between maternal ECR, RSA, ASRS and the 
change in child ADHD-RS over the 12  months of fol-
low up. Adjusted and unadjusted results are shown. 
The negative association between RSA and the out-
come (b = − 1.76; 95% CI − 3.45, − 0.07) suggests that a 
higher degree of maternal resilience is associated with 
larger reductions in child ADHD-RS during treatment. 
The significant association between maternal ASRS and 
child ADHD-RS (b = 3.48; 95% CI 1.76,5.20) suggests that 
children of mothers scoring higher on ADHD symptoms 
achieved a more modest treatment effect than children 
of mothers scoring lower on ADHD symptoms. There 
was no significant association between maternal ECR 
and the change in child ADHD-RS. The coefficients cor-
respond to the predicted absolute change in ADHD-RS 
from baseline to 12 months follow up when ECR, RSA or 
ASRS increase by one standard deviation.
Discussion
The current study was undertaken with the broad aim 
of attempting to shed further light on the role of mater-
nal functioning in the treatment response of children 
diagnosed with ADHD. Informed by the literature 
and existing empirical findings we chose to evaluate 
three domains of potential importance in maternal 
functioning: self-reported ADHD symptoms, self-
reported attachment style and degree of resilience. A 
sample of sixty-seven mother–child dyads with ADHD-
diagnosed children was recruited. The children and fami-
lies received care as usual, and treatment response was 
evaluated in terms of ADHD symptom-load measured at 
3 monthly intervals over a 1-year period. We anticipated 
that all three maternal functioning factors would corre-
late with treatment response, independent of treatment 
strategy.
The findings suggested a significant association 
between maternal self-reported ADHD symptoms and 
treatment outcome, measured by a reduction in chil-
dren’s reported ADHD symptoms. Thus, mothers scor-
ing high on ADHD symptoms had children who showed 
a lower reduction in ADHD symptoms at the 12 months’ 
follow up.
Contrary to expectations, we found no significant cor-
relation between maternal self-reported attachment style 
on the ECR and child outcome on the ADHD-RS.
Lastly and in line with our prediction, we found a nega-
tive association between maternal resilience as meas-
ured by the RSA and offspring treatment response on the 
ADHD-RS. This suggested that a higher degree of resil-
ience in mothers was associated with greater symptom-
reduction in their children receiving care as usual.
The correlation between maternal ADHD symptoma-
tology and treatment outcome of children with ADHD 
may be increased level of conflict in the parent–child 
relationship and exacerbated negative parenting [52]. 
Harvey and colleagues found that parental ADHD symp-
tomatology was associated with a number of factors in 
Table 3 Overall ADHD-RS reduction predicted by ECR, RSA and ASRS
N = 64. Linear regression using full information maximum likelihood estimator. ECR, RSA and ASRS are standardized factor scores used only in separate models. 
Outcome is the reduction in ADHD-RS score during 12 months follow up. It is predicted in a mixed effects regression including all information available. Crude and 
adjusted estimates are controlled for baseline ADHD-RS
ASRS 1.1 Adult ADHD Self-Report Scale, RSA Resilience Scale for Adults, ECR Experiences in Close Relationships
* p < 0.05, ** p < 0.01, *** p < 0.001
Crude Adjusted
b 95% CI b 95% CI
ECR − 1.68 [− 3.38, 0.02] − 1.18 [− 2.91, 0.55]
RSA − 1.98 [− 3.66, − 0.31]* − 1.76 [− 3.45, − 0.07]*
ASRS 3.44 [1.78, 5.10]*** 3.48 [1.76, 5.20]***
Control variables
 Female (ref. male) 0.30 [− 3.06, 3.66]
 Age at baseline − 0.29 [− 1.55, 0.98]
 Split family (ref. nuclear) 0.09 [− 2.88,3.07]
 In medical treatment (ref. not) − 5.32 [− 8.79, − 1.84]**
 Psych. disp. (no psych. Disp.) − 1.21 [− 5.71,3.29]
 Missed out follow ups 0.30 [− 1.86,2.46]
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parenting practices and quality of parent–child interac-
tions. This is supported by the findings of a number of 
studies, suggesting that maternal psychiatric history is 
significantly associated with child symptom severity and 
that there is a need for parental screening and treatment 
programs developed specifically for families in need [53, 
54].
Regarding ADHD and attachment, these have been 
found to constitute mutual risk factors and show exten-
sive overlap in symptomatology, [55]. However, our 
results did not support a correlation between maternal 
attachment style and treatment outcome in offspring 
ADHD. Notably, the ECR assesses attachment-related 
thoughts and feelings in adult romantic relationships and 
belongs to the social psychological tradition, whereas 
instruments such as the Adult Attachment Interview 
(AAI) represent the developmental assessment tradition 
[56]. These alternative traditions in assessing attach-
ment have been found to be only partly overlapping [57]. 
However, we have assessed the mother–child dyads using 
the AAI as well, and found that the AAI did not corre-
late with short-term treatment outcome either [58]. One 
explanation for this unexpected finding may be that 
maternal psychopathology is a more important predictor 
than attachment representations in offspring treatment 
outcome.
In terms of risk and resilience, numerous studies have 
documented the relationship between parental risk fac-
tors and child development. For example; association 
between family structure and mental wellbeing of chil-
dren (rate of readmissions to hospital) were investigated 
and pointed to the significance of family trauma and fam-
ily psychiatric history [59]. Further, in a meta-analysis of 
clinical samples, maternal functioning was found to be 
more important than factors in the child in shaping the 
quality of infant-mother attachment relationship [60].
Resilient child development despite adversity and how 
to promote resilient parenting are topics of increasing 
interest [61–63]. Surprisingly, however, few studies to 
date have investigated the potential influence of maternal 
resilience on treatment outcome in children with psycho-
pathology, and specifically those diagnosed with ADHD. 
Our findings suggest that maternal resilience may be a 
significant factor in predicting how the child diagnosed 
with ADHD responds to treatment. In line with this, 
a study on parenting practices found the combination 
of family risk, protection and parenting practices to be 
highly predictive of child functioning [64]. This under-
lines the need to consider resources as well as risk factors.
As resilience is generally regarded as a more stable 
trait than psychiatric symptoms [65] it may prove to be a 
powerful predictor and a core maternal feature in overall 
prognosis in children affected by various psychiatric 
symptoms.
Some studies in ADHD treatment have focused on par-
enting training and social skills training for children with 
ADHD. However, the evidence has not been convincing 
[66–69] which may result from lack of focus on mater-
nal functioning, such as own unmet need for treatment 
[70]. This omission in the field needs to be addressed by 
future studies placing greater emphasis on examining 
the relationship between maternal functioning and child 
treatment in the prediction of developmental outcomes. 
This is underlined by the fact that our findings were sig-
nificant in the domains of maternal ADHD symptoms 
and resilience regardless of treatment strategy, as not all 
children received medical treatment. Factors in maternal 
functioning may potentially provide a basis for more dif-
ferentiated treatment strategies in the future. This may in 
turn improve the general prognosis in ADHD.
Methodological considerations
This study is unique in representing the first attempt at 
exploring the role of maternal functioning in predict-
ing treatment response of children with ADHD; an area 
which has been lacking in previous studies [15, 16].
The study is, to our knowledge, one of very few stud-
ies to address maternal resources as well as risk factors 
simultaneously and it clearly raises important questions 
for future research.
Nevertheless, the current study has several limitations.
Our study had a naturalistic design and applied consec-
utive recruiting in order to include and follow a sample 
representative of the population we intended to investi-
gate. This was to keep selection bias to a minimum, and 
hence, we further kept the research track separated from 
the clinical treatment during the 1-year follow up. How-
ever, since a little more than half declined to participate, 
this then resulted in selection bias. When asked, the par-
ticipant’s main reason for declining to participate was 
due to the stress of the many appointments entailed by 
the clinical track.
Further, another limitation relates to the duration of 
the follow up period. As factors in the parent–child rela-
tionship are likely to emerge over time, a longer follow up 
would have been ideal.
For example, the lack of correlation between mater-
nal self-reported attachment style and child outcome on 
ADHD-RS may relate to the relatively short follow up 
period. This is supported by findings from other studies 
suggesting that the influence of medical treatment tends 
to wear off, making other factors more influential in long-
term treatment strategies [71, 72].
Another limitation concerns the sole reliance on 
self-reporting in the assessment of various aspects of 
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maternal functioning as socially desirable responding has 
been shown to affect results in previous research [73]. 
However, it has been shown that adults provide an accu-
rate assessment of their own ADHD symptoms [74].
Also, maternal ADHD symptomatology was assessed 
very specifically; other types of maternal psychopathol-
ogy were not assessed and thus taken into considera-
tion. For example, as maternal depression is known to 
be a risk factor for symptom severity in offspring ADHD 
[19], it would have been of interest to gain information 
on how many mothers were clinically depressed. We did, 
however, obtain general information on history of mental 
illness, from preformed protocols collecting psychoso-
cial and demographic data, which was controlled for in 
the analysis. The same is also true of the assessment of 
the children, as the degree of impairment in the children 
was not assessed beyond an assessment of their ADHD 
symptoms.
Disappointingly, we were not able to draw any con-
clusions in relation to the role of fathers’ functioning 
in the treatment response of their children diagnosed 
with ADHD. The response rate of fathers was too low 
to include in the study. Whilst this is not unique to our 
study (see for example, [75]), previous findings do sug-
gest a link between child externalizing problems and 
paternal ADHD symptoms, and this may constitute an 
area of particular interest for future research [54].
Compared to other reported studies, the rate of 
comorbidity was very low in our study [76, 77]. How-
ever, it would appear that ADHD is a clinical predictor 
of comorbidities, as ADHD seems to increase the risk of 
developing comorbidity during childhood and adoles-
cence such as conduct disorder and oppositional defiance 
disorder, which further increase the risk of antisocial 
behavior and juvenile delinquency later on ([11, 13, 78, 
79].This developmental pathway was also observed in a 
longitudinal study in which children were included only 
if they had no comorbidity [12]. Yet, in this study by Klein 
and colleagues, 84 of 135 participants developed prob-
able or definite conduct disorder during adolescence and 
a further 25% of these developed antisocial personality 
disorder in adulthood. The children in our study were 
included after a first time referral and were in the age 
range 7–12. Hence, the frequency of comorbid disorders 
may rise in the years to come.
Conclusion
Taken together, our findings suggest that risk factors as 
well as protective factors in maternal functioning have an 
impact on treatment outcome in children with ADHD. 
This underlines the potential value of a broader assess-
ment of maternal functioning, including screening of 
mothers for ADHD symptoms. This would permit the 
identification of parents with unmet needs for treatment 
and support, which might in turn lead to a better progno-
sis for their children. On the other hand, a greater focus 
on protective factors such as maternal resilience may be 
no less important in differentiating the subgroups of fam-
ilies who are at less of an immediate risk and who may 
therefore require less support and intervention.
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